ライフサイエンスコーパス: University of Pennsylvania

1 ital of Philadelphia and the Hospital of the University of Pennsylvania.

2 gen receptor T-cell therapy developed at the University of Pennsylvania.

3 or antibodies to DNER at the hospital of the University of Pennsylvania.

4 Diseases and Center for AIDS Research of the University of Pennsylvania.

5 ice and Oncology Unit of the Hospital of the University of Pennsylvania (2009-2010).

6 ar disease (CVD) in women by following 1,564 University of Pennsylvania alumnae (mean age, 45.5 years

7 , and April 31, 2013, at the Hospital of the University of Pennsylvania, an academic medical center.

8 noma were collected from the Hospital of the University of Pennsylvania and the radiologic archives o

9 Antibody studies were performed at the University of Pennsylvania and the University of Barcelo

10 on: 4.4% (Baylor), 8.0% (Georgetown), 32.6% (University of Pennsylvania), and 45.0% (Mount Sinai).

11 st Chair of the Department of Surgery at the University of Pennsylvania, and Dorsey's uncle), the new

12 rs: University of California, San Francisco, University of Pennsylvania, and Duke University.

13 n college athletes at Harvard University and University of Pennsylvania, as well as the follow-up of

14 utive series of WOP and IIT performed at the University of Pennsylvania between September 2001 and Fe

15 orted by the Cardiovascular Institute of the University of Pennsylvania, by the MedStar Health Resear

16 All of the endophenotypes and the University of Pennsylvania Computerized Neurocognitive B

17 ber Sequencing test, and 6 measures from the University of Pennsylvania Computerized Neurocognitive B

18 Hammond as professor, and the University of Pennsylvania created a clinical professors

19 ts who underwent ERCP at the Hospital of the University of Pennsylvania, from 2009 and 2015, includin

20 The NIH and University of Pennsylvania groups reported the detection

21 The University of Pennsylvania Health System in Philadelphia

22 January 1, 2005 to June 1, 2013, within the University of Pennsylvania Health System were identified

23 through December 31, 2016, performed at the University of Pennsylvania Health System, a tertiary ref

24 inistered by the Center for Bioethics at the University of Pennsylvania Health System, extensively re

25 e recruited from oncology clinics within the University of Pennsylvania Health System.

26 d fifty-one probands ascertained through the University of Pennsylvania high-risk clinic, all with co

27 med for 80 patients from the Hospital of the University of Pennsylvania (HUP) listed from July 1986 t

28 ents were recruited from the hospital of the University of Pennsylvania in Philadelphia, PA, USA.

29 eld professorships at McGill University, the University of Pennsylvania, Johns Hopkins University, an

30 In 1991, 80% of University of Pennsylvania medical students felt that nu

31 dings in an independent ADHF cohort from the University of Pennsylvania (n = 876).

32 Microbiology Testing Laboratory (MTL) of the University of Pennsylvania over a 2-year period.

33 Predictors of outcome were determined at the Universities of Pennsylvania (PA, USA) and Barcelona (Sp

34 2 cohorts: (1) consecutive admissions at the University of Pennsylvania (Penn) with a primary dischar

35 University of Pennsylvania Perelman School of Medicine.

36 nia, Berkeley), Donald Ringe and Ann Taylor (University of Pennsylvania, Philadelphia), and me, for a

37 ion therapy (n = 218) at the Hospital of the University of Pennsylvania, Philadelphia, or RT (n = 766

38 Mesothelioma Conference that was held at the University of Pennsylvania, Philadelphia, PA, May 13-16,

39 erous German-speaking scholars coming to the University of Pennsylvania, Philadelphia, with Albert Kl

40 STIM1 promoter using the TESS search system (University of Pennsylvania) revealed four putative respo

41 8 to 2001; n = 26,291) and those seen by the University of Pennsylvania's Pigmented Lesion Group (PLG

42 The University of Pennsylvania School of Medicine has develo

43 school faculty with disabilities, drawing on University of Pennsylvania School of Medicine initiative

44 tion Education and Prevention Program at the University of Pennsylvania School of Medicine is a succe

45 s Hopkins University School of Medicine, the University of Pennsylvania School of Medicine, the Unive

46 administration and core faculty group at the University of Pennsylvania School of Medicine.

47 Participants were evaluated with the 40-item University of Pennsylvania Smell Identification Test (UP

48 All were administered the University of Pennsylvania Smell Identification Test (UP

49 All participants were administered the University of Pennsylvania Smell Identification Test (UP

50 >/=8.90), sense of smell assessed using the University of Pennsylvania Smell Identification Test (UP

51 tilt positions using two different measures: University of Pennsylvania Smell Identification Test and

52 University of Pennsylvania Smell Identification Test dat

53 10-item scale performed comparably with the University of Pennsylvania Smell Identification Test in

54 nts and 100 lowest-risk participants, median University of Pennsylvania Smell Identification Test sco

55 The University of Pennsylvania Smell Identification Test was

56 The University of Pennsylvania Smell Identification Test was

57 , and at 2 years, significant differences in University of Pennsylvania Smell Identification Test, Un

58 le factors), a keyboard-tapping task and the University of Pennsylvania Smell Identification Test.

59 ification was also assessed using a modified University of Pennsylvania Smell Identification Test.

60 on tomography and olfactory testing with the University of Pennsylvania Smell Identification Test.

61 40 normal subjects was compared by using the University of Pennsylvania Smell Identification Test.

62 y controls, in four olfactory tasks: (i) the University of Pennsylvania smell identification test; (i

63 In multivariate analyses, baseline age, University of Pennsylvania Smell Inventory Test (UPSIT)

64 Dr Ruth J Muschel (University of Pennsylvania) spoke about work, conducted

65 w of students tested for tuberculosis at the University of Pennsylvania Student Health Service betwee

66 was completed in 1813 by John Syng Dorsey, a University of Pennsylvania surgeon.

67 to a previous brain scanner developed at the University of Pennsylvania, the HEAD Penn-PET, but the d

68 ortium and the Abramson Cancer Center of the University of Pennsylvania was convened on December 1, 2

69 red by The National Cancer Institute and the University of Pennsylvania, was held from December 1 to

70 Hospital, Johns Hopkins University, and the University of Pennsylvania were included.

71 radiation from June 1992 to June 1998 at the University of Pennsylvania were reviewed.

72 ts seen in the Dermatology Department of the University of Pennsylvania, who were diagnosed with nonm

73 er patients treated from 1977 to 1995 at the University of Pennsylvania with conventional tangential

74 lant recipients between 2002 and 2006 at the University of Pennsylvania with follow-up through 2010.